| Patents for C07C 233 - Carboxylic acid amides (28,881) |
|---|
| 05/15/2003 | US20030092747 Secretase inhibitor |
| 05/15/2003 | US20030092715 Aryl and biaryl compounds having MCH modulatory activity |
| 05/15/2003 | US20030092634 Novel compounds and compositions as protease inhibitors |
| 05/15/2003 | CA2466284A1 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 05/14/2003 | EP1310507A2 Novel peptide nucleic acids |
| 05/14/2003 | EP1310481A1 Process for the preparation of N-formyl-aminocarboxylic acid esters |
| 05/14/2003 | EP1309575A1 Biphenyl derivatives and their use as ppar-gamma receptor activators |
| 05/14/2003 | EP1309552A1 Compounds and inhibitors of phospholipases |
| 05/14/2003 | EP1169699B1 Magnetic recording medium with lubricant |
| 05/14/2003 | EP1140798B1 Process for the preparation of flowable concentrated betaine solution |
| 05/14/2003 | EP0667772B1 Taxanes having an alkyl substituted side-chain and pharmaceutical compositions containing them |
| 05/14/2003 | CN1418185A Aniline-derived ligands for thyroid receptor |
| 05/14/2003 | CN1417202A Preparation process of N-formamido carboxylic ester |
| 05/13/2003 | US6563003 Process to produce amino alcohol salts |
| 05/13/2003 | US6563002 Biscyclopropanecarboxamide compounds and pharmaceutical use thereof |
| 05/13/2003 | US6562995 Amidomethyl esters, carbonylmercaptomethyl esters, keto-containing esters, amidomethyl thioesters, amidomethyl amides, and methylene dithioesters are disclosed. The novel compounds have two carbonyl groups connected by a linking moiety having |
| 05/13/2003 | US6562962 Preparation of substituted isoserine esters using metal alkoxides and β-lactams |
| 05/13/2003 | US6562861 Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors |
| 05/13/2003 | US6562817 Suppressants of the IgE production |
| 05/08/2003 | WO2003038523A2 Polycarbocyclic derivatives for modification of resist, optical and etch resistance properties |
| 05/08/2003 | WO2003037865A1 Novel anticancer compounds |
| 05/08/2003 | WO2003037847A1 Benzamide derivatives as antagonists of orexin receptors |
| 05/08/2003 | WO2003037831A2 Method for preparing 4-nitroso-substituted aromatic amine |
| 05/08/2003 | WO2002076928A3 Alkylamine derivatives as antifouling agents |
| 05/08/2003 | WO2002026750A8 Phosphino-aminophosphines, catalyst complexes and enantioselective hydrogenation |
| 05/08/2003 | WO2002024715A3 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers |
| 05/08/2003 | US20030088128 Diaryl ether condensation reactions |
| 05/08/2003 | US20030088125 Unsaturated amide (acrylamide or methacrylamide), sulfur-containing compound (thiourea) and a weak acid salt (sodium acrylate); polymerization inhibition |
| 05/08/2003 | US20030088123 Process for preparing sulphuric methacrylamide and device for implementing it |
| 05/08/2003 | US20030088122 Method of preparing amino carboxylic acids |
| 05/08/2003 | US20030088111 Protected forms of pharmacologically active agents and uses therefor |
| 05/08/2003 | US20030087930 Process for preparing 2-(4-chlorobenzolamino)-3[ (1h)-quinolinon-4-yl] propionic acid |
| 05/08/2003 | US20030087905 Containing a haloalkyl group: e.g., 3-((3-(3-trifluoromethoxyphenoxy) phenyl)((3-(1,1,2,2-tetrafluoroethoxy)phenyl)methyl)amino)-1,1,1-trifluoro-2-propanol |
| 05/08/2003 | US20030087307 Compound for use in the prevention and treatment of respiratory and nervous system disorders |
| 05/08/2003 | CA2468761A1 Novel anticancer compounds |
| 05/07/2003 | EP1308436A1 Calcium receptor antagonists |
| 05/07/2003 | EP1307426A1 Amino diphenyl ethers and amido diphenyl ethers |
| 05/07/2003 | EP1307425A1 Novel n-(2-phenyl-3-aminopropyl)naphtamides |
| 05/07/2003 | EP1228034A4 Chiral phosphines, transition metal complexes thereof and uses thereof in asymmetric reactions |
| 05/07/2003 | EP1068181B1 Polyethoxylated retinamide derivatives and process for preparing the same |
| 05/07/2003 | EP1019358B1 3,3-diarylpropylamines , their use and preparation |
| 05/07/2003 | EP0889916B1 High refractive index hydrogels prepared from polymers and copolymers of n-benzyl-n-methylacrylamide |
| 05/07/2003 | EP0792270B1 Use of 2,7,8-trimethyl-2-(beta-carboxyethyl)-6-hydroxy chroman (LLU-alpha) |
| 05/07/2003 | EP0749417B1 Cyano compounds and preparations thereof |
| 05/07/2003 | EP0709386B1 Fused benzazepine derivative and pharmaceutical composition containing the same |
| 05/06/2003 | US6559341 Phthalic acid diamide derivatives, fluorine-containing aniline compounds as starting material, agricultural and horticultural insecticides, and a method for application of the insecticides |
| 05/06/2003 | US6559310 Aryl borates |
| 05/06/2003 | US6559261 A method for producing a polymeric material, said method comprising subjecting a starting material which includes two multiple bonds which are activated so that they will take part in a polymerisation reaction and wherein the multiple bonds |
| 05/06/2003 | US6559185 Nitromethyl ketone compounds having aldose reduction inhibiting properties and methods for their use |
| 05/06/2003 | CA2056068C Process |
| 05/02/2003 | EP1305798A2 Optical storage using materials comprising chromophore oligomers which can undergo cycloaddition |
| 05/02/2003 | EP1305324A1 Use of chiral diphosphines as optically active ligands |
| 05/02/2003 | EP1305304A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor |
| 05/02/2003 | EP1305292A1 Biphenyl carboxamides |
| 05/02/2003 | EP0941231B1 Heteroarylic-arylic diphosphines as chiral ligands |
| 05/02/2003 | EP0831799B1 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders |
| 05/01/2003 | WO2003035602A1 Lipid modulators |
| 05/01/2003 | WO2003035013A1 Hydrolysis stable self-etching, self-priming adhesive |
| 05/01/2003 | WO2003006443A3 2- 4-(naphtalin-2-yl)-thiazol-2-ylaminocarbonyl benzoic acid and 2- 4-(naphtalin-2-yl)-pyrimidin-2-ylaminocarbonyl benzoic acid and additional compounds serving as telomerase inhibitors for use in tumor therapy |
| 05/01/2003 | WO2002055454A3 Process and product |
| 05/01/2003 | WO2002026701A3 Ionic liquids and their use as solvents |
| 05/01/2003 | WO2002024642A8 Method for producing δ1-pyrrolines |
| 05/01/2003 | US20030083524 Nitro-benzamide useful as anti-arrhythmic agent |
| 05/01/2003 | US20030083513 Functional alcohol releasing substance |
| 05/01/2003 | US20030083503 Synthesis of acylated keto amides from sulfonyl amides |
| 05/01/2003 | US20030083341 2,3,5-Substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia |
| 05/01/2003 | US20030083331 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
| 05/01/2003 | US20030082631 Detecting modulator of peroxisome proliferator-activated receptor; obtain sample contain proxisome receptor, incubate with test agent, monitor sample for adjustment in receptor activity |
| 04/30/2003 | CN1414849A Carboxylic acid amides, medicaments containing these compounds and the use and preparation thereof |
| 04/30/2003 | CN1107051C Process for preparation of N-(4-fluorine-phenyl)-N-isopropyl-chloroacetamide |
| 04/29/2003 | US6555710 Aminobenzophenones as inhibitors of IL-1 β and TNF-α |
| 04/29/2003 | US6555709 Aromatic amides, their preparation process and their use as pesticides |
| 04/29/2003 | US6555708 Using non-pulverized N-epsilon long chain acyllysine crystal having an average particle diameter of from 3-15 mu m. in cosmetics to reduced stickimess and gloss by irregular light reflection; good feeling and spreadability |
| 04/29/2003 | US6555690 Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity |
| 04/29/2003 | US6555580 Treating arteriosclerosis and hypercholesterolaemia |
| 04/29/2003 | US6555562 2-Carboxybenzoyl-(N'-3,5-dichloroisonicotinoyl)-L-4aminophenyl alanine, for example; inhibit the binding of alpha-4 integrins to their ligands, use to treat immune or inflammatory disorders |
| 04/29/2003 | US6555120 Isolation, structural determination, synthesis, biological activity and application as control agent of the host marking pheromone (and derivatives thereof) of the fruit flies of the type anastrepha (diptera: tephritidae) |
| 04/29/2003 | CA2323461C Improved alkanolamides |
| 04/24/2003 | WO2003034071A2 A method of forming a dynamic combinatorial library using a scaffold |
| 04/24/2003 | WO2003033510A1 Novel chiral ligands, transition metal complexes thereof, and the catalytic use of the same |
| 04/24/2003 | WO2003033437A2 A method of forming neuraminidase inhibitors by dynamic combinatorial chemistry and compounds obtained |
| 04/24/2003 | WO2003032999A1 Alkyne matrix metalloproteinase inhibitors |
| 04/24/2003 | WO2003032972A1 5’-carbamoyl-1,1-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2003 | WO2003032970A1 5'-carbamoyl-2'-methyl-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2003 | WO2003032929A2 Cosmetic and personal care compositions |
| 04/24/2003 | WO2003002489A3 Solid-phase electrophilic fluorination |
| 04/24/2003 | WO2002098850A3 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors |
| 04/24/2003 | WO2002058690A3 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors |
| 04/24/2003 | US20030078440 O- or S- substituted tetrahydronaphthalene derivatives useful as regulators of cell proliferation and differentiation, useful for treating skin-related diseases |
| 04/24/2003 | US20030078436 Process for the catalytic preparation of N-acylglycine derivatives |
| 04/24/2003 | US20030078417 For protecting cells from injury due to intrinsic membrane lysis, oxidation and/or invasion by destructive agents; for therapy of phospholipase mediated injury, injury due to oxidation, and inflammation |
| 04/24/2003 | US20030078339 Degradable cross-linking agents and cross-linked network polymers formed therewith |
| 04/24/2003 | US20030078302 As carriers for delivering active agents such as peptides, drugs by administration, such as oral, subcutaneous, sublingual, and intranasal administration |
| 04/24/2003 | US20030078287 For controlling plant and animal pests |
| 04/24/2003 | CA2462442A1 Alkyne matrix metalloproteinase inhibitors |
| 04/23/2003 | WO2002034713A1 Process for producing b-form nateglinide crystal |
| 04/23/2003 | EP1303503A2 Aniline derivatives |
| 04/23/2003 | EP1102739B1 Glucocorticoid and thyroid hormone receptor ligands for the treatment of metabolic disorders |
| 04/23/2003 | EP0915846B1 2- and 2,5-substituted phenylketoenols |
| 04/23/2003 | EP0904264B1 Compositions for increasing the mri contrast in visualising the digestive tract of patients |